This course fulfills an unmet need – the need for a universal and comprehensive tool to educate oncology APs in the safe prescribing of cancer therapy
LAWRENCEVILLE, N.J. (PRWEB)
February 01, 2023
The Advanced Practitioner Society for Hematology and Oncology (APSHO) is proud to announce the launch of the APSHO Cancer Therapy Prescribing Course (CTPC). This comprehensive, online course consists of 19 self-paced, interactive educational modules designed to prepare the advanced practitioner (AP) to safely prescribe and manage cancer therapeutics. The Cancer Therapy Prescribing Course provides peer-reviewed, advanced education in the treatment and management of the hematology/oncology patient through the course of cancer therapy and includes safe prescribing recommendations, treatment access devices, the prevention and management of infusion reactions, patient education, and clinical trial prescribing.
“This course fulfills an unmet need – the need for a universal and comprehensive tool to educate oncology APs in the safe prescribing of cancer therapy,” commented APSHO’s Executive Director Wendy Vogel, MSN, FNP, AOCNP®, FAPO. “We believe that APs should practice at the top of their professional scope; this course, in conjunction with appropriate mentorship by the cancer institution, will enable them to do so.”
Briana Hoffner, MSN, AOCNP®, FAPO, BroadcastMed’s Chief Medical Officer, noted, “APSHO’s Cancer Therapy Prescribing Course was developed by an expert, dedicated, multidisciplinary group of APs, including pharmacists, physician assistants, and nurse practitioners. The course encompasses all of the required educational domains for the safe prescribing of cancer therapy.”
The CTPC will offer 25 credits/hours of CE-certified education for nurse practitioners, pharmacists, physician assistants, and advanced practice nurses. The course will be housed online in APSHO’s new AP Academy, found online at apsho.org/page/apacademy, along with other educational opportunities.Learn more about APSHO at APSHO.org.
About APSHO
The Advanced Practitioner Society for Hematology and Oncology (APSHO) is a society for advanced practitioners: nurse practitioners, physician assistants, pharmacists, clinical nurse specialists, and other oncology health-care professionals. The mission of APSHO is to promote oncology patient care that is high quality, cost effective, and delivered through collaborative practice models by optimizing the role of the advanced practitioner as an integral member of the care team.
Share article on social media or email: